Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
39.00
Dollar change
+1.39
Percentage change
3.70
%
IndexRUT P/E- EPS (ttm)-2.95 Insider Own9.29% Shs Outstand95.64M Perf Week-2.40%
Market Cap3.73B Forward P/E- EPS next Y-3.36 Insider Trans-10.52% Shs Float86.75M Perf Month32.16%
Income-228.68M PEG- EPS next Q-0.84 Inst Own91.78% Short Float12.48% Perf Quarter61.83%
Sales10.87M P/S343.14 EPS this Y-6.95% Inst Trans-0.74% Short Ratio8.34 Perf Half Y328.10%
Book/sh8.69 P/B4.49 EPS next Y-8.03% ROA-29.22% Short Interest10.82M Perf Year230.51%
Cash/sh9.58 P/C4.07 EPS next 5Y- ROE-32.91% 52W Range4.82 - 42.00 Perf YTD330.94%
Dividend Est.- P/FCF- EPS past 5Y-57.60% ROI-27.34% 52W High-7.14% Beta0.88
Dividend TTM- Quick Ratio12.47 Sales past 5Y148.90% Gross Margin64.89% 52W Low708.29% ATR (14)2.40
Dividend Ex-Date- Current Ratio12.47 EPS Y/Y TTM12.25% Oper. Margin-2347.64% RSI (14)72.79 Volatility6.06% 7.07%
Employees253 Debt/Eq0.01 Sales Y/Y TTM12.50% Profit Margin-2103.78% Recom1.00 Target Price62.25
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-6.13% Payout- Rel Volume3.26 Prev Close37.61
Sales Surprise36.18% EPS Surprise0.77% Sales Q/Q58.67% EarningsMay 09 AMC Avg Volume1.30M Price39.00
SMA2026.60% SMA5040.31% SMA200153.58% Trades Volume4,228,920 Change3.70%
Date Action Analyst Rating Change Price Target Change
May-03-24Initiated BofA Securities Buy $40
Mar-14-24Initiated Cantor Fitzgerald Overweight $60
May-22-23Upgrade Evercore ISI In-line → Outperform $20
Mar-31-23Downgrade Evercore ISI Outperform → In-line $20
Jul-20-22Initiated Chardan Capital Markets Buy $29
Jul-12-22Initiated Raymond James Strong Buy $29
Sep-07-21Initiated Evercore ISI Outperform $50
Jun-17-21Initiated Needham Buy $50
Apr-26-21Resumed Credit Suisse Outperform $37
Jul-07-20Initiated Wells Fargo Overweight $60
Jun-21-24 04:05PM
Jun-20-24 09:00AM
Jun-17-24 04:05PM
Jun-14-24 09:00AM
Jun-13-24 08:00PM
10:39AM Loading…
10:39AM
Jun-12-24 04:04PM
04:01PM
07:45AM
07:00AM
May-29-24 04:05PM
08:45AM
May-23-24 06:00AM
May-21-24 04:05PM
May-19-24 09:03AM
03:24AM Loading…
May-17-24 03:24AM
May-15-24 09:00AM
May-09-24 11:55PM
04:05PM
May-08-24 04:05PM
12:27PM
06:00AM
Apr-22-24 04:05PM
Apr-04-24 01:30AM
Mar-27-24 09:00AM
Mar-21-24 04:05PM
Mar-15-24 07:01PM
Mar-04-24 04:02PM
07:00AM
Feb-29-24 12:00PM
07:00AM Loading…
07:00AM
Feb-28-24 05:20PM
04:40PM
04:05PM
Feb-27-24 09:00AM
Feb-26-24 06:55AM
Feb-21-24 04:05PM
Feb-20-24 09:00AM
Feb-15-24 05:00PM
Jan-29-24 08:54AM
Jan-22-24 04:05PM
Jan-05-24 08:30AM
Dec-21-23 04:05PM
Dec-13-23 08:30AM
Nov-29-23 09:03AM
Nov-28-23 10:09AM
10:02AM
07:01AM
06:30AM
Nov-21-23 04:05PM
09:00AM
Nov-08-23 06:12PM
04:05PM
Oct-23-23 04:05PM
Oct-07-23 07:30AM
Sep-26-23 09:00AM
Sep-25-23 09:00AM
Sep-21-23 04:05PM
Sep-11-23 07:28PM
Sep-07-23 09:00AM
Aug-31-23 09:00AM
Aug-30-23 09:00AM
Aug-21-23 04:05PM
Aug-15-23 09:00AM
Aug-08-23 07:15PM
04:05PM
Jul-21-23 04:05PM
Jul-12-23 07:24AM
Jun-21-23 04:05PM
Jun-20-23 09:00AM
Jun-08-23 09:00AM
May-22-23 04:05PM
May-17-23 12:38PM
07:00AM
May-09-23 06:15PM
04:05PM
May-04-23 09:00PM
Apr-28-23 10:08AM
Apr-27-23 03:40PM
Apr-24-23 09:00AM
Apr-21-23 04:05PM
Apr-17-23 09:00AM
Apr-13-23 09:00AM
Apr-11-23 11:23AM
Apr-05-23 10:14AM
Mar-31-23 11:44AM
Mar-30-23 04:16PM
03:25PM
07:00AM
Mar-25-23 10:17AM
Mar-21-23 04:05PM
Mar-13-23 09:00AM
Mar-01-23 04:05PM
Feb-28-23 07:45PM
04:05PM
09:00AM
Feb-27-23 04:40PM
08:00AM
Feb-23-23 08:00AM
Feb-21-23 08:29PM
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVIN ARTHUR ADirectorJun 20 '24Option Exercise1.245,0006,20019,830Jun 21 04:19 PM
LEVIN ARTHUR ADirectorJun 20 '24Sale37.595,000187,95014,830Jun 21 04:19 PM
Boyce SarahPresident and CEOJun 18 '24Sale39.1332,0741,255,040142,543Jun 20 06:47 PM
MacLean Michael FChief Financial OfficerJun 18 '24Sale39.1311,228439,34557,865Jun 20 06:48 PM
Flanagan W. MichaelCSTOJun 18 '24Sale39.1310,106395,44550,765Jun 20 06:47 PM
McCarthy TeresaChief Human Resources OfficerJun 18 '24Sale39.139,864385,97232,171Jun 20 06:49 PM
Boyce SarahPresident and CEOJun 14 '24Option Exercise1.2435,76744,351147,884Jun 14 06:58 PM
Boyce SarahPresident and CEOJun 14 '24Sale40.0835,7671,433,484112,117Jun 14 06:58 PM
Boyce SarahPresident and CEOJun 13 '24Option Exercise1.24164,233203,649276,350Jun 14 06:58 PM
Boyce SarahPresident and CEOJun 13 '24Sale40.08164,2336,581,802112,117Jun 14 06:58 PM
LEVIN ARTHUR ADirectorJun 13 '24Sale40.0860,0002,404,782153,872Jun 14 07:03 PM
MacLean Michael FChief Financial OfficerJun 12 '24Option Exercise8.82104,245919,441148,338Jun 14 07:07 PM
Boyce SarahPresident and CEOJun 12 '24Option Exercise1.24100,000124,000212,117Jun 14 06:58 PM
MacLean Michael FChief Financial OfficerJun 12 '24Sale35.72104,2453,723,14144,093Jun 14 07:07 PM
Boyce SarahPresident and CEOJun 12 '24Sale35.73100,0003,573,020112,117Jun 14 06:58 PM
LEVIN ARTHUR ADirectorJun 12 '24Sale35.0740,0001,402,628213,872Jun 14 07:03 PM
Boyce SarahPresident and CEOJun 04 '24Option Exercise1.2428,00034,720140,117Jun 05 05:46 PM
Boyce SarahPresident and CEOJun 04 '24Sale27.4228,000767,780112,117Jun 05 05:46 PM
LEVIN ARTHUR ADirectorMay 20 '24Option Exercise1.245,0006,20019,830May 21 05:05 PM
LEVIN ARTHUR ADirectorMay 20 '24Sale29.905,000149,48114,830May 21 05:05 PM
MacLean Michael FChief Financial OfficerMay 14 '24Option Exercise8.8275,000661,500119,093May 16 06:25 PM
MacLean Michael FChief Financial OfficerMay 14 '24Sale28.2875,0002,121,04544,093May 16 06:25 PM
Boyce SarahPresident and CEOMay 07 '24Option Exercise1.2428,00034,720140,117May 07 09:52 PM
Boyce SarahPresident and CEOMay 07 '24Sale25.5428,000715,050112,117May 07 09:52 PM
LEVIN ARTHUR ADirectorApr 19 '24Option Exercise1.245,0006,20019,830Apr 22 05:28 PM
LEVIN ARTHUR ADirectorApr 19 '24Sale22.825,000114,12314,830Apr 22 05:28 PM
LEVIN ARTHUR ADirectorApr 03 '24Sale27.1120,000542,214253,872Apr 03 08:26 PM
Boyce SarahPresident and CEOApr 02 '24Option Exercise1.2428,00034,720140,117Apr 03 06:16 PM
Boyce SarahPresident and CEOApr 02 '24Sale26.2528,000734,919112,117Apr 03 06:16 PM
LEVIN ARTHUR ADirectorMar 19 '24Option Exercise1.245,0006,20019,830Mar 21 04:10 PM
LEVIN ARTHUR ADirectorMar 19 '24Sale23.975,000119,84814,830Mar 21 04:10 PM
MacLean Michael FChief Financial OfficerMar 13 '24Option Exercise8.8240,000352,80084,093Mar 15 04:12 PM
MacLean Michael FChief Financial OfficerMar 13 '24Sale24.5240,000980,76044,093Mar 15 04:12 PM
Boyce SarahPresident and CEOMar 12 '24Option Exercise1.2428,00034,720140,117Mar 12 05:29 PM
LEVIN ARTHUR ADirectorMar 12 '24Option Exercise1.2425,00031,00042,471Mar 12 08:41 PM
Boyce SarahPresident and CEOMar 12 '24Sale22.6328,000633,682112,117Mar 12 05:29 PM
LEVIN ARTHUR ADirectorMar 12 '24Sale22.0327,641609,01714,830Mar 12 08:41 PM
Boyce SarahPresident and CEOMar 08 '24Option Exercise1.2484,000104,160196,117Mar 12 05:29 PM
Boyce SarahPresident and CEOMar 08 '24Sale21.3984,0001,796,710112,117Mar 12 05:29 PM
Boyce SarahPresident and CEOMar 01 '24Option Exercise1.2484,000104,160196,117Mar 05 04:53 PM
Boyce SarahPresident and CEOMar 01 '24Sale20.1384,0001,691,306112,117Mar 05 04:53 PM
Boyce SarahPresident and CEOJan 22 '24Sale10.135,09251,58244,008Jan 23 03:13 PM
Flanagan W. MichaelCSTOJan 22 '24Sale10.134,12941,82735,871Jan 23 03:12 PM
McCarthy TeresaChief Human Resources OfficerJan 22 '24Sale10.132,06520,91817,035Jan 23 03:11 PM
LEVIN ARTHUR ADirectorJan 22 '24Sale10.131,85918,83217,471Jan 23 03:14 PM
MacLean Michael FChief Financial OfficerJan 22 '24Sale10.131,61616,37016,884Jan 23 03:11 PM